Category: Case Study
Focused Monitoring Support for Rare Disease Study A small biotech needed functional support for a Phase III rare disease study. Although a contract
existed between the biotech and a clinical research organization (CRO), the study timelines and budget
had slipped. The biotech hired Catalyst Flex to reverse that trend and ultimately saved ~$1 million. Read Now 
Catalyst Flex on Rapid CRA Deployment Catalyst Flex provides expert clinical research professionals Catalyst Flex engages highly skilled and experienced industry Read Now 
Partnering to Overcome Compliance Challenges Catalyst Flex Partners with TrialKit An innovative medical device company contracted with Catalyst Flex for Read Now 
Executive Safety Support Long-term global pharmacovigilance assistance Catalyst Oncology provided a range of pharmacovigilance services for an active Read Now 
Safe and Sound Supporting pharmacovigilance during global expansions Catalyst Oncology contracted for studies across several indications and countries. Read Now 
Rapid First Person In Milestone Less than 2 months for an oncology drug and device development company A drug and Read Now 
Catalyst Oncology FIH Rescue Study A clinical-stage biotech company with a critical startup milestone Catalyst Oncology transitioned full-service work from Read Now 
Global Full-service Phase III Ovarian Cancer Study Catalyst Oncology succeeds in delivering for late clinical-stage oncology biotech. While the biotech had experience Read Now 
Flexible Data Management for Growing Portfolio Catalyst Flex enhances biopharma client’s capabilities A small biopharma client wanted to enhance its in-house Read Now 
Phase III Rare Disease Study Catalyst Flex Assists Biotech for Research Program A small biotech with limited internal capacity outsourced Read Now